Axcelis vs Ametek: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Axcelis Technologies Inc (ACLS)

Q3 20266 Aug – 28 Sep 2026

▲3

Axcelis Beats Q2, Raises 2026 Outlook, Expands Korea Capacity

Q2 Beat and Raised 2026 Revenue Outlook Axcelis reported Q2 revenue of $215.2 million and EPS of $1.06, both above its own forecasts, and raised full-year 2026 revenue growth to mid-single digits from flat. This directly lifts profit expectations and supports a higher stock price.
The earnings beat and guidance raise are the core new fundamental catalyst for ACLS this period.
$35M Korea Plant Expands Capacity in Key Region Axcelis will invest $35 million in a new ion implantation factory in Pyeongtaek, Korea, its second-largest revenue region. The plant adds capacity and shows commitment to rising semiconductor demand, though output starts only in late 2028, so near-term earnings impact is limited.
This is a concrete new investment that signals growth and capacity expansion, a positive for long-term demand.
Growth Outlook Solid but Margins Under Pressure Management expects mid-single-digit 2026 revenue growth and further growth in 2027, driven by memory, power, and aftermarket demand. However, gross margin fell to 42.7% from 45.2% and operating margin dropped to 14.7% from 17.7%, a real counterweight to the positive revenue story.
It gives the balanced picture: revenue growth is positive, but margin decline is a negative that could cap price gains.
Veeco Merger Nears Final China Approval The pending all-stock merger with Veeco has all regulatory clearances except China antitrust approval and remains on track to close in the second half of 2026. Progress reduces uncertainty and supports the stock, though the deal is not yet complete.
Merger progress is a key overhang being resolved, directly affecting ACLS's price and strategic future.

September 20266 Aug – 28 Sep 2026

▲3

Axcelis Beats Q2, Raises 2026 Outlook, Expands Korea Capacity

Q2 Beat and Raised 2026 Revenue Outlook Axcelis reported Q2 revenue of $215.2 million and EPS of $1.06, both above its own forecasts, and raised full-year 2026 revenue growth to mid-single digits from flat. This directly lifts profit expectations and supports a higher stock price.
The earnings beat and guidance raise are the core new fundamental catalyst for ACLS this period.
$35M Korea Plant Expands Capacity in Key Region Axcelis will invest $35 million in a new ion implantation factory in Pyeongtaek, Korea, its second-largest revenue region. The plant adds capacity and shows commitment to rising semiconductor demand, though output starts only in late 2028, so near-term earnings impact is limited.
This is a concrete new investment that signals growth and capacity expansion, a positive for long-term demand.
Growth Outlook Solid but Margins Under Pressure Management expects mid-single-digit 2026 revenue growth and further growth in 2027, driven by memory, power, and aftermarket demand. However, gross margin fell to 42.7% from 45.2% and operating margin dropped to 14.7% from 17.7%, a real counterweight to the positive revenue story.
It gives the balanced picture: revenue growth is positive, but margin decline is a negative that could cap price gains.
Veeco Merger Nears Final China Approval The pending all-stock merger with Veeco has all regulatory clearances except China antitrust approval and remains on track to close in the second half of 2026. Progress reduces uncertainty and supports the stock, though the deal is not yet complete.
Merger progress is a key overhang being resolved, directly affecting ACLS's price and strategic future.

Latest6 Aug – 28 Sep 2026

▲3

Axcelis Beats Q2, Raises 2026 Outlook, Expands Korea Capacity

Q2 Beat and Raised 2026 Revenue Outlook Axcelis reported Q2 revenue of $215.2 million and EPS of $1.06, both above its own forecasts, and raised full-year 2026 revenue growth to mid-single digits from flat. This directly lifts profit expectations and supports a higher stock price.
The earnings beat and guidance raise are the core new fundamental catalyst for ACLS this period.
$35M Korea Plant Expands Capacity in Key Region Axcelis will invest $35 million in a new ion implantation factory in Pyeongtaek, Korea, its second-largest revenue region. The plant adds capacity and shows commitment to rising semiconductor demand, though output starts only in late 2028, so near-term earnings impact is limited.
This is a concrete new investment that signals growth and capacity expansion, a positive for long-term demand.
Growth Outlook Solid but Margins Under Pressure Management expects mid-single-digit 2026 revenue growth and further growth in 2027, driven by memory, power, and aftermarket demand. However, gross margin fell to 42.7% from 45.2% and operating margin dropped to 14.7% from 17.7%, a real counterweight to the positive revenue story.
It gives the balanced picture: revenue growth is positive, but margin decline is a negative that could cap price gains.
Veeco Merger Nears Final China Approval The pending all-stock merger with Veeco has all regulatory clearances except China antitrust approval and remains on track to close in the second half of 2026. Progress reduces uncertainty and supports the stock, though the deal is not yet complete.
Merger progress is a key overhang being resolved, directly affecting ACLS's price and strategic future.

Ametek Inc (AME)

Q3 202625 Jul – 19 Sep 2026

▲3

Ametek's record quarter and $5B deal drive growth outlook

Record Q2 results and raised guidance Ametek reported record second-quarter sales of $2.04 billion, up 15%, with adjusted earnings of $2.09 per share, beating expectations. Management raised full-year adjusted EPS guidance to $8.25 at the midpoint, signaling confidence in continued momentum. This strong performance pushes the stock up because it shows the company is growing faster than expected and is likely to keep doing so.
This is the core positive event that directly boosts investor confidence and the stock price.
Completed $5B Indicor acquisition Ametek closed its $5.0 billion all-cash purchase of Indicor Instrumentation, expected to add about $350 million to 2026 sales and be modestly accretive to earnings. This acquisition expands Ametek's product offerings and customer base, which should drive future growth and support a higher stock price.
The acquisition is a major strategic move that adds revenue and earnings, directly impacting the company's value.
Exceptional order growth signals strong demand Ametek's orders grew 28% in the second quarter, the second straight quarter of what the company called exceptional demand. This suggests customers are buying more of Ametek's products, which should lead to higher future sales and profits, pushing the stock up.
Order growth is a leading indicator of future revenue, so it directly supports a positive price outlook.
Valuation debate and stock pullback Despite strong results, Ametek's stock fell 5.1% after the Q2 report to $231.44, and analysts debate whether it's undervalued or overvalued. One model sees fair value at $259, another at $174.60. This tug-of-war can cause price swings, but the underlying business strength remains the main driver.
It provides a balanced view by acknowledging that valuation concerns and recent price weakness could temper gains.

August 202625 Jul – 19 Sep 2026

▲3

Ametek's record quarter and $5B deal drive growth outlook

Record Q2 results and raised guidance Ametek reported record second-quarter sales of $2.04 billion, up 15%, with adjusted earnings of $2.09 per share, beating expectations. Management raised full-year adjusted EPS guidance to $8.25 at the midpoint, signaling confidence in continued momentum. This strong performance pushes the stock up because it shows the company is growing faster than expected and is likely to keep doing so.
This is the core positive event that directly boosts investor confidence and the stock price.
Completed $5B Indicor acquisition Ametek closed its $5.0 billion all-cash purchase of Indicor Instrumentation, expected to add about $350 million to 2026 sales and be modestly accretive to earnings. This acquisition expands Ametek's product offerings and customer base, which should drive future growth and support a higher stock price.
The acquisition is a major strategic move that adds revenue and earnings, directly impacting the company's value.
Exceptional order growth signals strong demand Ametek's orders grew 28% in the second quarter, the second straight quarter of what the company called exceptional demand. This suggests customers are buying more of Ametek's products, which should lead to higher future sales and profits, pushing the stock up.
Order growth is a leading indicator of future revenue, so it directly supports a positive price outlook.
Valuation debate and stock pullback Despite strong results, Ametek's stock fell 5.1% after the Q2 report to $231.44, and analysts debate whether it's undervalued or overvalued. One model sees fair value at $259, another at $174.60. This tug-of-war can cause price swings, but the underlying business strength remains the main driver.
It provides a balanced view by acknowledging that valuation concerns and recent price weakness could temper gains.

Latest25 Jul – 19 Sep 2026

▲3

Ametek's record quarter and $5B deal drive growth outlook

Record Q2 results and raised guidance Ametek reported record second-quarter sales of $2.04 billion, up 15%, with adjusted earnings of $2.09 per share, beating expectations. Management raised full-year adjusted EPS guidance to $8.25 at the midpoint, signaling confidence in continued momentum. This strong performance pushes the stock up because it shows the company is growing faster than expected and is likely to keep doing so.
This is the core positive event that directly boosts investor confidence and the stock price.
Completed $5B Indicor acquisition Ametek closed its $5.0 billion all-cash purchase of Indicor Instrumentation, expected to add about $350 million to 2026 sales and be modestly accretive to earnings. This acquisition expands Ametek's product offerings and customer base, which should drive future growth and support a higher stock price.
The acquisition is a major strategic move that adds revenue and earnings, directly impacting the company's value.
Exceptional order growth signals strong demand Ametek's orders grew 28% in the second quarter, the second straight quarter of what the company called exceptional demand. This suggests customers are buying more of Ametek's products, which should lead to higher future sales and profits, pushing the stock up.
Order growth is a leading indicator of future revenue, so it directly supports a positive price outlook.
Valuation debate and stock pullback Despite strong results, Ametek's stock fell 5.1% after the Q2 report to $231.44, and analysts debate whether it's undervalued or overvalued. One model sees fair value at $259, another at $174.60. This tug-of-war can cause price swings, but the underlying business strength remains the main driver.
It provides a balanced view by acknowledging that valuation concerns and recent price weakness could temper gains.